HTBT

HTBT is a biopharmaceutical manufacturer that focuses on international biotechnology introduction and absorption.

Number of Funding Rounds

Total Funding Amount

5

¥143M

HTBT has raised a total of ¥143M in funding over 2 rounds. Their latest funding was raised on Oct 13, 2015 from a Series E round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 13, 2015	Series E	¥50M	2	—	—	Detail
Sep 9, 2014	Series D	¥50M	1	—	—	Detail
Dec 1, 2013	Series C	¥30M	1	Haoshi Touzi	—	Detail
May 28, 2012	Series A	¥10M	1	Premier Prophet Assets Management	—	Detail
Apr 26, 2011	Angel	¥3M	1	—	—	Detail

Number of Lead Investors

Number of Investors

2

6

HTBT is funded by 6 investors. Haoshi Touzi and Premier Prophet Assets Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Haoshi Touzi	Yes	Series C
Premier Prophet Assets Management	Yes	Series A
Kashen Kaize Chuangtou	—	Series E
Shanghai Guxin Touzi	—	Series E
Shanghai Dalan Touzi	—	Series D
Quanji Fuju Touzi	—	Angel